NEW YORK (GenomeWeb News) – Althea Technologies said today that Advanced BioScience Laboratories has awarded it a cGMP manufacturing contract worth $911,549 to produce a DNA-based HIV-1 vaccine.
The multi-year contract is under a master agreement with the US National Institutes of Health and funded by the National Institute of Allergy and Infectious Diseases, Althea said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.